Asia · Regional markets · Yicai Global

China’s Hengrui Pharma Soars Amid Strong Earnings Growth in First Nine Months Driven by Innovative Drug Business

Published by Yicai Global · China 16 h ago

Revenue from the innovative drug out-licensing business surged over 31 percent to CNY2.8 billion in the first three quarters from a year ago, mainly thanks to revenue recognized…

Read the full article on Yicai Global Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.yicaiglobal.com)

Also worth reading

Business Standard

SAT sets aside ₹1.49 crore MCX penalty on Ventura over invalid order

The Straits Times Business

Amazon gives Alexa night vision and a bedside role in smart home battle

The Business Times

About 11,000 homes planned on Maju Forest, Gillman Barracks sites with more greenery to be retained

Tech in Asia

Delivery Hero raises 2026 outlook on quick-commerce growth

Business Recorder

Qatari mediators present Iran with new deal to end the war, official says

The Financial Express